News Daily News Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label? Yael L. Maxwell December 23, 2016
News Features The Bioresorbable Stent Story So Far: What Promise? What Price? Michael O'Riordan August 17, 2016
News Conference News TCT 2015 Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award October 12, 2015
News Daily News Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery Caitlin E. Cox June 15, 2015
News Daily News Halving DES Use in Low-Risk Patients Could Save $200 Million Annually Yael L. Maxwell July 11, 2012